Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Balancing Bleeding and Thrombosis in Lung Adenocarcinoma – JTH
Thomas Fusillo/ LinkedIn
Jul 19, 2026, 10:40

Balancing Bleeding and Thrombosis in Lung Adenocarcinoma – JTH

Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Thomas Fusillo et al. published in JTH, adding:

“Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and VEGF or EGFR inhibitors

Clinicians often worry about combining anticoagulation with targeted cancer drugs.

In patients with lung adenocarcinoma, giving anticoagulants alongside VEGF or EGFR inhibitors was not associated with a statistically significant rise in major or clinically relevant non-major bleeding.

The data offer some reassurance for treating thrombosis in this group, though careful patient selection still applies.”

Title: Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor receptor inhibitors

Authors: Thomas F. Fusillo, Avi Leader, Simon Mantha, Helen Ajufo, Andriy Derkach, Adam Schoenfeld, Rohan Singh, Peter Kaplinsky, Jeffrey I. ZwickerBalancing Bleeding and Thrombosis in Lung Adenocarcinoma - JTH

Stay updated on all scientific advances with Hemostasis Today.

Adam Schoenfeld Andriy Derkach Avi Leader bleeding eGFR Health Helen Ajufo Hematology Hemostasis Hemostasis News Hemostasis Today Jeffrey I. Zwicker JTH Lung Adenocarcinoma Medicine Peter Kaplinsky Rohan Singh Simon Mantha Thomas F. Fusillo VEGF
NewsFeed